Edition:
United States

Novelion Therapeutics Inc (NVLN.OQ)

NVLN.OQ on NASDAQ Stock Exchange Global Select Market

3.09USD
4:00pm EDT
Change (% chg)

$-0.22 (-6.65%)
Prev Close
$3.31
Open
$3.32
Day's High
$3.32
Day's Low
$3.07
Volume
6,980
Avg. Vol
23,017
52-wk High
$7.27
52-wk Low
$2.97

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 31.90 -1.667
Mar '18 27.48 -1.755
FY 2017 Dec '17 38.91 -1.316
Sep '17 28.67 -2.668
Jun '17 40.88 -1.152
Mar '17 29.98 -1.670
FY 2016 Dec '16 13.57 -1.482
Sep '16 0.00 -0.562
Jun '16 0.00 -0.485
Mar '16 0.00 -2.072
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 2 35.15 36.10 34.20 --
Quarter Ending Dec-18 2 42.40 43.60 41.20 --
Year Ending Dec-18 2 136.95 137.20 136.70 160.65
Year Ending Dec-19 2 167.60 187.90 147.30 189.20
Earnings (per share)
Quarter Ending Sep-18 2 -0.71 0.07 -1.49 --
Quarter Ending Dec-18 2 -0.56 0.16 -1.27 --
Year Ending Dec-18 2 -4.69 -3.20 -6.18 -1.21
Year Ending Dec-19 2 -2.53 1.30 -6.35 -0.43
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 109.17 32.55
P/E High - Last 5 Yrs. -- 280.12 47.13
P/E Low - Last 5 Yrs. -- 98.84 24.86
Beta 0.91 0.61 0.87
Price to Sales (TTM) 0.49 110.45 6.32
Price to Book (MRQ) -- 12.64 3.96
Price to Tangible Book (MRQ) -- 19.10 6.00
Price to Cash Flow (TTM) -- 63.46 22.84
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.68
Dividend Yield - 5 Year Avg -- 0.21 1.45
Dividend 5 Year Growth Rate -- 2.60 -5.90
Payout Ratio(TTM) -- 5.94 46.65

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -21.95 175.06 8.33
Sales (TTM) vs TTM 1 Yr. Ago 50.37 95.32 6.69
Sales - 5 Yr. Growth Rate -- 24.62 7.54
EPS (MRQ) vs Qtr. 1 Yr. Ago -44.67 282.02 25.23
EPS (TTM) vs TTM 1 Yr. Ago -52.18 -- --
EPS - 5 Yr. Growth Rate -- 23.81 7.60
Capital Spending - 5 Yr. Growth Rate -3.31 38.47 8.36

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.13 1.65 2.21
Current Ratio (MRQ) 1.33 5.52 2.98
LT Debt to Equity (MRQ) -- 15.14 11.20
Total Debt to Equity (MRQ) -- 18.66 14.01
Interest Coverage (TTM) -2.33 -209.98 34.72

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 40.37 55.96 54.70
Gross Margin - 5 Yr. Avg. -- 52.62 53.20
EBITD Margin (TTM) -51.66 -- --
EBITD - 5 Yr. Avg -118.62 -178.18 15.84
Operating Margin (TTM) -73.04 -606.83 3.87
Operating Margin - 5 Yr. Avg. -117.86 -191.65 10.99
Pre-Tax Margin (TTM) -107.81 -603.48 4.20
Pre-Tax Margin - 5 Yr. Avg. -151.93 -194.31 11.19
Net Profit Margin (TTM) -109.01 -598.39 0.91
Net Profit Margin - 5 Yr. Avg. -152.90 -191.85 7.51
Effective Tax Rate (TTM) -- 11.63 20.56
Effective Tax Rate - 5 Yr. Avg. -- 19.21 24.33

Efficiency

  Company industry sector
Revenue/Employee (TTM) 705,361 5,345,588 725,212,627
Net Income/Employee (TTM) -768,900 -5,897,254 83,818,761
Receivable Turnover (TTM) 7.98 4.23 5.04
Inventory Turnover (TTM) 3.93 2.07 3.63
Asset Turnover (TTM) 0.33 0.38 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -35.46 0.80 9.83
Return on Assets - 5 Yr. Avg. -17.40 2.68 10.96
Return on Investment (TTM) -45.79 1.47 12.80
Return on Investment - 5 Yr. Avg. -19.90 2.23 14.08
Return on Equity (TTM) -657.09 0.22 14.92
Return on Equity - 5 Yr. Avg. -29.31 -2.55 15.41
  1 Year 3 Year 5 Year
Sales % 919.88 -- --
EPS (TTM) % -45.27 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Novelion Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 0.30 -0.47 61 66
13 Week -6.50 -12.98 45 67
26 Week -2.65 -11.34 52 45
52 Week -51.11 -58.09 18 87
YTD 6.09 -2.84 60 82
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 83.01%
# of Holders: 66
Total Shares Held: 15,649,428
3 Mo. Net Change: 94,210
# New Positions: 8
# Closed Positions: 37
# Increased Positions: 17
# Reduced Positions: 53
# Net Buyers: -36
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.